EUVIMEDEUVIMED entdecken
Open Access

Complete Blood Cell Count-Derived Inflammatory Biomarkers in Early-Stage Non-Small-Cell Lung Cancer

Fumihiro Shoji, Yuka Kozuma, Gouji Toyokawa, Koji Yamazaki, Sadanori Takeo

Annals of Thoracic and Cardiovascular Surgery · 2020 · 26 (5) · 248-255

DOI: 10.5761/atcs.oa.19-00315 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Thoracic and Cardiovascular Surgery, 2020. Verfasst von Fumihiro Shoji und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Clinical Research Institute, National Hospital Organization, Kyushu Medical Center, Fukuoka, Fukuoka, Japan. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Complete blood cell count (CBC)-derived inflammatory biomarkers are widely used as prognostic parameters for various malignancies, but the best predictive biomarker for early-stage non-small-cell lung cancer (NSCLC) is unclear. We retrospectively analyzed early-stage NSCLC patients to investigate predictive effects of preoperative CBC-derived inflammatory biomarkers. PATIENTS AND METHODS: We selected 311 consecutive patients with pathological stage IA NSCLC surgically resected from April 2006 to December 2012. Univariate and multivariate Cox proportional analyses of recurrence-free survival (RFS) were used to test the preoperative systemic immune inflammation index (SII), neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), and monocyte-lymphocyte ratio (MLR). RESULTS: Preoperative high MLR levels were significantly associated with patient sex, smoking status, and postoperative recurrence (p 2 cm had significantly shorter RFS than other subgroups (p = 0.0289). CONCLUSIONS: The preoperative MLR level is the optimal predictor of recurrence in patients with pathological stage IA NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdultAgedAged, 80 and overBlood PlateletsCarcinoma, Non-Small-Cell LungFemaleHumansInflammationLung NeoplasmsLymphocyte CountLymphocytesMaleMiddle AgedMonocytesNeoplasm Recurrence, LocalNeoplasm StagingNeutrophilsPlatelet CountPneumonectomyPredictive Value of Tests

Stichwörter der Autor:innen

complete blood cell count-derived inflammatory biomarkerspathological stage IA non-small-cell lung cancerprognostic factor

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Clinical Research Institute, National Hospital Organization, Kyushu Medical Center, Fukuoka, Fukuoka, Japan.

Zitieren

APA

Shoji, F., Kozuma, Y., Toyokawa, G., Yamazaki, K., & Takeo, S. (2020). Complete Blood Cell Count-Derived Inflammatory Biomarkers in Early-Stage Non-Small-Cell Lung Cancer. Annals of Thoracic and Cardiovascular Surgery, 26(5), 248-255. https://doi.org/10.5761/atcs.oa.19-00315

Vancouver

Shoji F, Kozuma Y, Toyokawa G, Yamazaki K, Takeo S. Complete Blood Cell Count-Derived Inflammatory Biomarkers in Early-Stage Non-Small-Cell Lung Cancer. Annals of Thoracic and Cardiovascular Surgery. 2020;26(5):248-255. doi:10.5761/atcs.oa.19-00315

BibTeX
@article{Shoji2020,
  author = {Shoji, Fumihiro and Kozuma, Yuka and Toyokawa, Gouji and Yamazaki, Koji and Takeo, Sadanori},
  title = {Complete Blood Cell Count-Derived Inflammatory Biomarkers in Early-Stage Non-Small-Cell Lung Cancer},
  journal = {Annals of Thoracic and Cardiovascular Surgery},
  year = {2020},
  volume = {26},
  number = {5},
  pages = {248--255},
  doi = {10.5761/atcs.oa.19-00315}
}
Kostenlos starten →